Purpose The aim of this study was to update the clinical practice guidelines for the use of
basic oral care (BOC) interventions for the prevention and/or treatment of oral mucositis …

Oral mucositis induced by conventional cytotoxic cancer therapies is a common and
significant clinical problem in oncology. Mucositis symptoms, which include severe pain …

Background Oral mucositis (OM) due to radiotherapy and systemic therapies in head and
neck cancer treatment represents a major problem causing a wide spectrum of clinical signs …

Aim The aims of the study are to determine the incidence of oral mucositis, the stage of the
condition, risk factors, and other oral complications in patients receiving outpatient …

Oral Mucositis (OM) is among the most common and dreaded toxicities of cancer therapy. It
occurs in almost all patients who receive radiation therapy in which areas of oral and …

Oral mucositis (OM) is one of the side effects of hematopoietic stem cell transplantation
(HSCT), resulting in major morbidity. The aim of this study was to determine the cost …

Febrile neutropenia (FN) is an inflammatory response causing fever that may develop during
cancer therapy-induced neutropenia. FN may herald life-threatening infectious …

Oral Diseases (2012) 19, 18–36 Objective: Solid organ transplant (SOT) and hematopoietic
stem cell transplant (HSCT) recipients are at risk of several diseases, principally attributable …

OBJECTIVES: Oral mucositis is a complication frequently associated with hematopoietic
stem cell transplantation, decreasing a patient's quality of life and increasing the occurrence …

Hematopoietic cell transplantation (HCT) is now one of the frequent procedures used for
treatment of malignant and non-malignant blood diseases, autoimmune disorders, and …